Furthermore increased XIAP levels have also been reported for ovarian carcinoma (42), B-cell Non-Hodgkin and Hodgkin lymphoma (43), clear cell renal cancer (44, 45), esophageal carcinoma (46), and non-small cell lung cancer (47). Here, XIAP is linked to ovarian carcinoma.